GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.UN) » Definitions » ROE % Adjusted to Book Value

DRI Healthcare Trust (TSX:DHT.UN) ROE % Adjusted to Book Value : -1.23% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust ROE % Adjusted to Book Value?

DRI Healthcare Trust's ROE % for the quarter that ended in Sep. 2024 was -1.28%. DRI Healthcare Trust's PB Ratio for the quarter that ended in Sep. 2024 was 1.04. DRI Healthcare Trust's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -1.23%.


DRI Healthcare Trust ROE % Adjusted to Book Value Historical Data

The historical data trend for DRI Healthcare Trust's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust ROE % Adjusted to Book Value Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
10.54 5.39 21.15

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.51 17.37 -3.73 -1.29 -1.23

Competitive Comparison of DRI Healthcare Trust's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's ROE % Adjusted to Book Value falls into.



DRI Healthcare Trust ROE % Adjusted to Book Value Calculation

DRI Healthcare Trust's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=19.67% / 0.93
=21.15%

DRI Healthcare Trust's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.28% / 1.04
=-1.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DRI Healthcare Trust ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


DRI Healthcare Trust Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

DRI Healthcare Trust Headlines

No Headlines